AsthmaDiscontinuationICS/LABANew userPersistenceAsthma is associated with significant economic burden. Inhaled corticosteroid and long-acting beta2-agonist (ICS/LABA) combination therapies are considered mainstays of treatment. We describe real-world use of ICS/LABAs by comparing treatment persistence and ...
Long-acting beta agonists (LABAs) seemed like life-savers when they first came out. They were prescribed indiscriminately, though, and as with short-acting beta agonists, it became clear that without controller therapy, these drugs posed a health risk. It came as no surprise toasthmaexperts tha...
Comparison between montelukast and inhaled beclomethasone therapy in chronic asthma: a double-blind, placebo-controlled, parallel study in asthmatic patients. Merck Research Laboratories 1999. 13. Yamauchi K, Tanifuji Y, Pan LH, et al. Effects of pranlukast, a leukotriene receptor antagon...
Another reason to explain the increase in fentanyl use compared to the downtrend of heroin is the supply and demand chain, where more fentanyl has become available in the streets in comparison to heroin in the last few years (Ciccarone, 2021). In addition, social and cultural factors are ...